Diabetes and pregnancy clinical guideline published

From diabetestimes.co.uk

A new guideline covering the management of glycaemic control in pregnant women with diabetes has been released.
The Joint British Diabetes Societies for Inpatient Care (JBDS–IP) has published the document to support existing processes in acute trusts providing care to pregnant women with diabetes admitted to hospital.
The guideline, Management of glycaemic control in pregnant women with diabetes on obstetric wards and delivery units, is the latest in the series of JBDS-IP guidelines developed to improve the standards of care for people with diabetes in secondary care.
Neonatal hypoglycaemia continues to affect up to 30 per of babies with the risk of impaired neurologic development of the child, but effective control of maternal glucose during pregnancy, delivery and birth has the potential to reduce this complication.
NICE has already produced evidence-based guidelines on the target blood glucose which should be maintained. The JBDS guideline attempts to provide a standardised template by which these targets can be safely and effectively achieved. Pregnant women are at higher risk of DKA and its adverse consequences. The guideline also provides a standardised protocol on how to recognise and treat DKA in the special situation of pregnancy.

Dr Umesh Dashora, Lead, Diabetes and Endocrinology, East Sussex Healthcare NHS Trust and senior lecturer, Brighton and Sussex Medical School, was one of the lead authors.He said: “Managing diabetes during delivery and while giving steroids for prematurity can be quite difficult. DKA may have significant adverse consequences for the mother and the baby in pregnancy. This guideline will help standardise management in these difficult clinical situations and help achieve NICE suggested glycaemic control targets.”
The other lead authors were Dr Rosemary Temple, consultant diabetes and Endocrinology, Norfolk and Norwich University Hospitals NHS Foundation Trust, as well as Professor Helen Murphy, Professor of Medicine (Diabetes and Antenatal Care), Norwich Medical School University of East Anglia and Honorary Consultant Addenbrooke’s Hospital Cambridge.

The guideline has been produced by JBDS-IP on behalf of Diabetes UK, the Association of British Clinical Diabetologists (ABCD) and the Diabetes Inpatient Specialist Nurse (DISN) UK Group.
As with all of the JBDS-IP documents, this guideline is dynamic and will be reviewed in response to feedback with a view to incorporating emerging evidence.
To download the guideline, click here.

http://diabetestimes.co.uk/diabetes-pregnancy-clinical-guideline-published/